All Stories

  1. Taste receptor downregulation in diet-induced obesity reveals circumvallate papillae-specific taste-inflammatory networks
  2. Sex-specific effects of peptidyl arginine deiminase 4 deficiency in the cafeteria diet-induced obesity-associated metabolic complications
  3. Cafeteria and Fast-Food Diets Induce Neuroinflammation, Social Deficits, but a Different Cardiometabolic Phenotype
  4. Association of plasma levels of protein-bound advanced glycation end-products and their soluble receptors with bone mineral status in young girls with the restrictive type of anorexia nervosa
  5. Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease
  6. Association of acrylamide dietary intake with glycation and oxidative status biomarkers and intakes of advanced glycation end-products or alpha-dicarbonyls
  7. Pathophysiological Role of Neutrophil Extracellular Traps in Diet-Induced Obesity and Metabolic Syndrome in Animal Models
  8. Mitochondrial DNA variability and Covid-19 in the Slovak population
  9. Association of Leukocyte, Erythrocyte, and Platelet Counts with Metabolic Syndrome and Its Components in Young Individuals without Overt Signs of Inflammation: A Cross-Sectional Study
  10. Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis
  11. In vivo Volumetric, DTI and 1H MRS Rat Brain Protocol for Monitoring Early Neurodegeneration and Efficacy of the Used Therapy
  12. Association of Atherogenic Index of Plasma with Cardiometabolic Risk Factors and Markers in Lean 14-to-20-Year-Old Individuals: A Cross-Sectional Study
  13. Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-To-45-Year-Old Females: A Cross-Sectional Study
  14. Severe gestational diabetes mellitus in lean dams is associated with low IL-1α levels and affects the growth of the juvenile mouse offspring
  15. Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study
  16. The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study
  17. Extracellular DNA concentrations in various aetiologies of acute kidney injury
  18. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?
  19. Lean insulin-resistant young adults display increased cardiometabolic risk: A retrospective cross-sectional study
  20. Long-Term Consumption of a Sugar-Sweetened Soft Drink in Combination with a Western-Type Diet Is Associated with Morphological and Molecular Changes of Taste Markers Independent of Body Weight Development in Mice
  21. The Effect of Long-Term Hypogonadism on Body Composition and Morphometry of Aged Male Wistar Rats
  22. Creatinine-Based Formulae Poorly Match in the Classification of Hypofiltration or Hyperfiltration in a General Population of Adolescents: A Retrospective Analysis of a Cross-Sectional Study
  23. A considerable proportion of metabolic syndrome–free adults from Bratislava Region, Slovakia, display an increased cardiometabolic burden
  24. Bone mineral density and oxidative stress in adolescent girls with anorexia nervosa
  25. Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents
  26. Oxidative status in plasma, urine and saliva of girls with anorexia nervosa and healthy controls: a cross-sectional study
  27. Neurodevelopmental testing of mice in the neonatal period does not affect their locomotor activity, depressive- and anxiety-like behaviour in adolescence
  28. Dynamics of salivary markers of kidney functions in acute and chronic kidney diseases
  29. Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents
  30. Sex Differences in Association of Elevated Blood Pressure with Variables Characterizing Cardiometabolic Risk in Young Subjects with or Without Metabolic Abnormalities
  31. Elevated blood pressure-associated cardiometabolic risk factors and biomarkers in 16–23 years old students with or without metabolic abnormalities
  32. Estimation of the proportion of metabolic syndrome-free subjects on high cardiometabolic risk using two continuous cardiometabolic risk scores: a cross-sectional study in 16- to 20-year-old individuals
  33. Maternal Consumption of a Diet Rich in Maillard Reaction Products Accelerates Neurodevelopment in F1 and Sex-Dependently Affects Behavioral Phenotype in F2 Rat Offspring
  34. Metabolic and Renal Effects of Dietary Advanced Glycation end Products in Pregnant Rats – A Pilot Study
  35. Markers of Oxidative Stress and Antioxidant Status in the Plasma, Urine and Saliva of Healthy Mice
  36. Glycated proteins in nutrition: Friend or foe?
  37. Gender-associated differences in the prevalence of central obesity using waist circumference and waist-to-height ratio, and that of general obesity, in Slovak adults
  38. Salivary creatinine and urea are higher in an experimental model of acute but not chronic renal disease
  39. Plasma markers of oxidative status were associated with increasing continuous cardiometabolic risk scores in healthy students aged 16-20 years without central obesity
  40. Prevalence of overweight/obesity among 7-year-old children—WHO Childhood Obesity Surveillance Initiative in Slovakia, trends and differences between selected European countries
  41. Oxidative stress in the brain caused by acute kidney injury
  42. The effects of a maternal advanced glycation end product-rich diet on somatic features, reflex ontogeny and metabolic parameters of offspring mice
  43. Continuous metabolic syndrome score (siMS) enables quantification of severity of cardiometabolic affliction in individuals not presenting with metabolic syndrome
  44. Gender Differences in Cardiometabolic Risk Factors in Metabolically Healthy Normal Weight Adults with Central Obesity
  45. Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus
  46. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
  47. Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and activity of semicarbazide-sensitive amine oxidase
  48. Variables associated with unplanned general adult ICU admission in hospitalised patients: protocol for a systematic review
  49. Vitamin D status in apparently healthy medication-free Slovaks: Association to blood pressure, body mass index, self-reported smoking status and physical activity
  50. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study
  51. Salivary markers of kidney function — Potentials and limitations
  52. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus
  53. Vitamin D Levels Decline with Rising Number of Cardiometabolic Risk Factors in Healthy Adults: Association with Adipokines, Inflammation, Oxidative Stress and Advanced Glycation Markers
  54. Presence of Cardiometabolic Risk Factors Is Not Associated with Microalbuminuria in 14-to-20-Years Old Slovak Adolescents: A Cross-Sectional, Population Study
  55. Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST
  56. Prenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats
  57. 25-Hydroxyvitamin D and Advanced Glycation Endproducts in Healthy and Hypertensive Subjects: Are There Interactions?
  58. Chronic renal insufficiency does not induce behavioral and cognitive alteration in rats
  59. Extraskeletal Functions of Vitamin D
  60. Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System
  61. Is Vitamin D Deficiency Related to Accumulation of Advanced Glycation End Products, Markers of Inflammation, and Oxidative Stress in Diabetic Subjects?
  62. A pilot study of a genetic CJD risk factor (E200K) in the general Slovak population
  63. 26. Advanced glycation end products in infant formulas
  64. Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? – In the search for minimizing of the adverse effects of PAMAM administration
  65. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects
  66. Skin autofluorescence reference values from newborns to adults
  67. Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine
  68. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats
  69. Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva
  70. Advanced Glycation End Products in Infant Formulas Do Not Contribute to Insulin Resistance Associated with Their Consumption
  71. Neuromuscular electrostimulation techniques: historical aspects and current possibilities in treatment of pain and muscle waisting
  72. Influence Of Intensive Exercise On Renal Functions (Rf) And Advanced Glycation End-Products (Ages)
  73. The Effects of Anti-Inflammatory and Anti-Angiogenic DNA Vaccination on Diabetic Nephropathy in Rats
  74. Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds
  75. Advanced Oxidation Protein Products and Advanced Glycation End Products in Children and Adolescents With Chronic Renal Insufficiency
  76. The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
  77. Association of sVAP-1, sRAGE, and CML with lactation-induced insulin sensitivity in young non-diabetic healthy women
  78. Advanced glycation end products in myocardial reperfusion injury
  79. Metabolic syndrome is inversely related to soluble receptor for advanced glycation end products: a study in mother-infant pairs
  80. Karl Peter’s fundamental contribution to the structural organization of the kidney
  81. AT1 Receptor Antagonist Candesartan Attenuates Genomic Damage in Peripheral Blood Lymphocytes of Patients on Maintenance Hemodialysis Treatment
  82. Renal and metabolic effects of three months of decarbonated cola beverages in rats
  83. AGEs Fluorescence of Plasma, Urine and Skin Reflects Dietary Exposure to Maillard Products in Formula-fed Infants
  84. Mechanisms of Acute Uremic Encephalopathy: Early Activation of Fos and Fra-2 Gene Products in Different Nuclei/Areas of the Rat Brain
  85. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers
  86. Oxidative stress, advanced glycation end products and residual renal function in the rat model of unilateral ureteral obstruction: effects of phlogenzym and losartan
  87. Advanced Glycation End Products and Acute Myocardial Infarction
  88. Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite
  89. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats
  90. Testing strategies for the safety of nanoparticles used in medical applications
  91. Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project
  92. Neuronal activation in the CNS during different forms of acute renal failure in rats
  93. Plasma advanced glycation end products are decreased in obese children compared with lean controls
  94. Functional and Partial Morphological Regression of Established Renal Injury in the Obese Zucker Rat by Blockade of the Renin-Angiotensin System
  95. Entwicklung der Peritonealdialyse
  96. Einfluss proteolytischer Enzyme auf Advanced Glycation Endproducts (AGEs) – Mögliche klinische Implikationen?
  97. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats
  98. Les produits de Maillard issus de la cuisson ont-ils des effets biologiques ?
  99. Plasma Concentration and Urinary Excretion of Nɛ-(Carboxymethyl)lysine in Breast Milk- and Formula-fed Infants
  100. Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function
  101. The Selective TP Receptor Antagonist, S18886 (Terutroban), Attenuates Renal Damage in the Double Transgenic Rat Model of Hypertension
  102. Dietary advanced glycation endproducts (AGEs) and their health effects - PRO
  103. Treatment targets in renal fibrosis
  104. Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes
  105. Reply
  106. Genomic Damage and Malignancy in End-Stage Renal Failure: Do Advanced Glycation End Products Contribute?
  107. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians
  108. Renal Disease in Obesity: The Need for Greater Attention
  109. Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients
  110. Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats
  111. Tissue viral DNA is associated with chronic allograft nephropathy
  112. Genetic variability in the RAGE gene: Possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications
  113. Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats
  114. Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It
  115. Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK-293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats
  116. Reduced Circulating AGE Levels and Lower Genomic Damage in Patients Undergoing Daily versus Standard Hemodialysis
  117. Advanced Glycation End Product-Induced DNA Damage: Involvement of Angiotensin II
  118. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis
  119. Genomic damage in chronic renal failure—potential therapeutic interventions
  120. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis
  121. Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation
  122. Genomic damage in end-stage renal failure: Potential involvement of advanced glycation end products and carbonyl stress
  123. Die Bedeutung von Übergewicht und Adipositas für Entstehung und Verlauf renaler Erkrankungen
  124. Serum Growth Factors in Hemodialyzed Patients
  125. Functional Hyperhomocysteinemia in Healthy Vegetarians: No Association with Advanced Glycation End Products, Markers of Protein Oxidation, or Lipid Peroxidation after Correction with Vitamin B12
  126. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products
  127. Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
  128. Genotoxicity of advanced glycation end products in mammalian cells
  129. Effects of dietary Nε-carboxymethyllysine on expression of the biotransformation enzyme, glutathione-S-transferase, in the rat
  130. Advanced glykation end products in patients with liver cirrhosis before and after liver transplantation
  131. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantation
  132. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet
  133. Plasma levels of advanced glycation end products in children with renal disease
  134. Advanced glycation end products and the progressive course of renal disease
  135. Advanced glycation end products (AGEs)‐induced expression of TGF‐β1 is suppressed by a protease in the tubule cell line LLC‐PK1
  136. DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan
  137. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin
  138. Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin
  139. DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan
  140. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure
  141. Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure
  142. Advanced Glycation End Products in End-Stage Renal Disease and Their Removal
  143. Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension
  144. Evidence for Accumulation of Advanced Glycation End Products in Acute Renal Failure
  145. Enalapril Inhibits Growth and Proliferation of Various Tissues in Rat Normotensive Four–Sixths Kidney Ablation Nephropathy
  146. The effect of oral protease administration in the rat remnant kidney model
  147. Suppressed Activities of Cathepsins and Metalloproteinases in the Chronic Model of Puromycin Aminonucleoside Nephrosis
  148. Advanced Glycation End-Product Levels in Subtotally Nephrectomized Rats: Beneficial Effects of Angiotensin II Receptor 1 Antagonist Losartan
  149. Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosage
  150. Mesangial cell hypertrophy induced by NH4Cl: Role of depressed activities of cathepsins due to elevated lysosomal pH
  151. High-Glucose Media Enhance the Responsiveness of Tubular Cells to Growth Promoters: Effect on Lysosomal Cathepsins and Protein Degradation
  152. Nutritional Management of the Uremic Patient
  153. Effect of Chronic Therapy with Proteolytic Enzymes on Hypertension-Induced Renal Injury in the Rat Model of Goldblatt Hypertension
  154. Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle
  155. Plasma Levels of 5-Hydroxyindole-Acetic Acid in Chronic Renal Insufficiency and Their Effect on Platelet Aggregation
  156. Serotonin and Platelet Activation During Treatment with Isradipine
  157. Serotonin and Platelet Activation During Treatment with Isradipine
  158. Serotonin Metabolism in Patients with Decreased Renal Function
  159. Perturbation of baseline in HPLC analysis as the consequence of sample injection
  160. Serotonin Metabolism and Platelet Aggregation Under Antihypertensive Treatment with Nitrendipine
  161. Evaluation of various bonded-phase materials for the off-line clean-up procedure of urinary 5-hydroxyindolacetic acid prior to its determination by HPLC
  162. Dependence of the separation of some biological substances on the carbon content of C18 chemically bonded phases